Literature DB >> 1329627

Photostability and biological activity of fluoroquinolones substituted at the 8 position after UV irradiation.

M Matsumoto1, K Kojima, H Nagano, S Matsubara, T Yokota.   

Abstract

Q-35 [1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methylaminopiperid ine-1-yl)-4-oxoquinoline-3-carboxylic acid], a fluoroquinolone, has absorbance peaks at 333 and 286 nm. No spectral change was observed even when this aqueous solution was irradiated with 3 J of long-wavelength UV light (UVA) per cm2. On the other hand, its derivatives, which are unsubstituted (8-H analog) or which are substituted with fluorine at the 8 position (8-F analog), were found to have decreased antibacterial activities with a simultaneous increase in their cytotoxicities when they were degraded in a dose-dependent manner with respect to UVA irradiation. Similar results were observed with the other available fluoroquinolones. Enoxacin and lomefloxacin exposed to 0.3 J of irradiation per cm2 and norfloxacin, ofloxacin, and ciprofloxacin exposed to 1 J of irradiation per cm2 underwent absorption spectrum changes, an accompanying decrease in antibacterial activity, and an increase in cytotoxic activity. These results suggest that the introduction of a methoxy group into the 8 position of quinolones plays an important role in the stability of fluoroquinolones against irradiation by UV light.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329627      PMCID: PMC192036          DOI: 10.1128/AAC.36.8.1715

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Phototoxic potential of quinolone antibacterial agents in Balb/c mice.

Authors:  N Wagai; F Yamaguchi; M Sekiguchi; K Tawara
Journal:  Toxicol Lett       Date:  1990-12       Impact factor: 4.372

2.  Loss of antibiotic activity caused by photodegradation: in vivo studies.

Authors:  J Ferguson; G Phillips; J McEwan; T Moreland; B E Johnson
Journal:  Br J Dermatol       Date:  1988-10       Impact factor: 9.302

3.  Ciprofloxacin-induced photosensitivity: in vitro and in vivo studies.

Authors:  J Ferguson; B E Johnson
Journal:  Br J Dermatol       Date:  1990-07       Impact factor: 9.302

4.  Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin.

Authors:  W R Bowie; V Willetts; P J Jewesson
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

5.  The efficacy and safety of ciprofloxacin and ofloxacin in chronic Pseudomonas aeruginosa infection in cystic fibrosis.

Authors:  T Jensen; S S Pedersen; C H Nielsen; N Høiby; C Koch
Journal:  J Antimicrob Chemother       Date:  1987-10       Impact factor: 5.790

6.  Antibacterial activity of lomefloxacin.

Authors:  D A Leigh; S Tait; B Walsh
Journal:  J Antimicrob Chemother       Date:  1991-05       Impact factor: 5.790

7.  Nalidixic acid-induced photodermatitis after minimal sun exposure.

Authors:  A Boisvert; G Barbeau
Journal:  Drug Intell Clin Pharm       Date:  1981-02

Review 8.  Specific toxicologic aspects of the quinolones.

Authors:  W Christ; T Lehnert; B Ulbrich
Journal:  Rev Infect Dis       Date:  1988 Jan-Feb

Review 9.  Adverse effects of the fluoroquinolones.

Authors:  H Halkin
Journal:  Rev Infect Dis       Date:  1988 Jan-Feb

10.  Photoonycholysis induced by the fluoroquinolones pefloxacine and ofloxacine. Report on 2 cases.

Authors:  R Baran; P Brun
Journal:  Dermatologica       Date:  1986
View more
  16 in total

1.  Evaluation of physical and chemical changes in pharmaceuticals flown on space missions.

Authors:  Brian Du; Vernie R Daniels; Zalman Vaksman; Jason L Boyd; Camille Crady; Lakshmi Putcha
Journal:  AAPS J       Date:  2011-04-09       Impact factor: 4.009

2.  Defluorinated sparfloxacin as a new photoproduct identified by liquid chromatography coupled with UV detection and tandem mass spectrometry.

Authors:  M Engler; G Rüsing; F Sörgel; U Holzgrabe
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

3.  Combined use of in vitro phototoxic assessments and cassette dosing pharmacokinetic study for phototoxicity characterization of fluoroquinolones.

Authors:  Yoshiki Seto; Ryo Inoue; Masanori Ochi; Graham Gandy; Shizuo Yamada; Satomi Onoue
Journal:  AAPS J       Date:  2011-07-08       Impact factor: 4.009

4.  In vitro and in vivo antibacterial activities of CS-940, a new fluoroquinolone, against isolates from patients with respiratory infections.

Authors:  S Miyazaki; H Domon; K Tateda; A Ohno; Y Ishii; T Matsumoto; N Furuya; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

Review 5.  A critical review of the fluoroquinolones: focus on respiratory infections.

Authors:  George G Zhanel; Kelly Ennis; Lavern Vercaigne; Andrew Walkty; Alfred S Gin; John Embil; Heather Smith; Daryl J Hoban
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 6.  Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections.

Authors:  J A Balfour; H M Lamb
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

7.  In vitro and in vivo activities of Q-35, a new fluoroquinolone, against Mycoplasma pneumoniae.

Authors:  Y Gohara; S Arai; A Akashi; K Kuwano; C C Tseng; S Matsubara; M Matumoto; T Furudera
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

8.  Photosensitivity reactions caused by lomefloxacin hydrochloride: a multicenter survey.

Authors:  J Arata; T Horio; R Soejima; K Ohara
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

9.  Reduced phototoxicity of a fluoroquinolone antibacterial agent with a methoxy group at the 8 position in mice irradiated with long-wavelength UV light.

Authors:  K Marutani; M Matsumoto; Y Otabe; M Nagamuta; K Tanaka; A Miyoshi; T Hasegawa; H Nagano; S Matsubara; R Kamide
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

Review 10.  Fluoroquinolone toxicities. An update.

Authors:  P S Lietman
Journal:  Drugs       Date:  1995       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.